Pages

Tuesday, March 28, 2017

FDA approves 1st drug for moderate & severe eczema cases

... list price of $37,000 per year, according to Paris, France-based Sanofi SA and Regeneron Pharmaceuticals of Tarrytown, New York , which developed the drug. The drug is an antibody that patients inject just under the skin every two weeks. It binds to ...
http://ift.tt/2neaSKc

No comments:

Post a Comment